CDK1 and hepatocellular carcinoma: Previous studies have demonstrated that the expression of CDK1 is increased in some human tumors, and an increase in CDK1 expression is associated with a poor prognosis for hepatocellular carcinoma and pancreatic ductal adenocarcinoma [10,32,33].